The government of Japan has included Bharat Biotech’s Covaxin in the list of recognised vaccines to further facilitate travel from India, said the Indian embassy on Thursday.
“Government of Japan includes the indigenously developed and manufactured Covid-19 vaccine Covaxin by Bharat Biotech of India, as one of the recognised vaccines for 1st and 2nd dose with effect from 10 April 2022 to further facilitate travel from India to Japan (sic),” the embassy took to Twitter to say.
Japan also recognises Pfizer’s Comirnaty, AstraZeneca’s Vaxzevria, COVID-19 vaccine by Moderna and Janssen COVID-19 vaccine.
COVID-19 vaccination certificates issued outside of Japan are accepted in Japan if they are in Japanese or English and contain the following information: name, date of birth, vaccine product name or manufacturer, vaccination date, and number of COVID-19 vaccine doses.
